the us scientists used low doses of the drug oxaliplatin , which has a unique ability to activate cancer killing immune cells in small tumours but works less well in large , aggressive tumours . tests of new drug oxaliplatin , carried out in combination with chemotherapy drugs , achieved almost complete remission in mice . each year in the uk around 41,000 men are diagnosed with prostate cancer and 11,000 die from the disease . the us scientists used low doses of the drug oxaliplatin , which has a unique ability to activate cancer killing immune cells in small tumours but works less well in large , aggressive tumours . the problem is partly caused by immune system b cells that put a brake on the body's defences in prostate and other cancers . tests carried out in combination with chemotherapy drugs achieved almost complete remission in mice . 